CAR-T cell therapy is one of the newest and most promising treatments available for blood cancer. These treatments aid in the battle against cancer by utilizing your body's immune system.
Factors affecting the cost of CAR-T:
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Development and Manufacturing Costs: The scientific manipulation of a patient's T-cells to generate chimeric antigen receptors that specifically target cancer cells is the basis for CAR-T treatment. CAR-T cell development and production are intricate and costly processes requiring specialized laboratory equipment and methods. The total cost of CAR-T therapy is greatly increased by these up-front expenses.
- Type of Cancer: Certain cancers, including some forms of leukemia and lymphoma, have been approved for treatment with CAR-T therapy. The cost of CAR-T therapy and the intricacy of the treatment regimen may vary depending on the particular form of cancer being treated.
- Post-treatment Monitoring and Support: After receiving CAR-T therapy, patients need to be closely watched for any adverse effects, such as neurotoxicity and cytokine release syndrome (CRS), and their response to treatment needs to be continuously assessed. The total cost of treatment should account for the expenses of supportive care, side effect control, and monitoring following treatment.
- Geographic Location: The cost of healthcare varies by nation and location. Healthcare expenditures, even those for cutting-edge treatments like CAR-T therapy, are typically higher in urban areas or in locations with higher cost of living.
- Supply and Demand Dynamics: CAR-T therapy availability may be restricted in some areas, and treatment costs may be impacted by supply and demand dynamics. The possibility exists that treatment prices could go down over time as more facilities start to provide CAR-T therapy and as manufacturing procedures become more efficient.
| Country | Cost | Local_currency |
|---|---|---|
| United Kingdom | USD 373000 | 294670 |
| Turkey | USD 443200 | 13358048 |
| Spain | USD 375000 | 345000 |
| United States | USD 289550 | 289550 |
| Singapore | USD 251388 | 336860 |
CAR T-cell therapy represents a groundbreaking approach to harnessing the power of the body's immune system to combat cancer. By modifying T cells, a subset of white blood cells, in a laboratory setting, these cells are empowered to recognize and eliminate cancer cells with precision. Often categorized as a form of cell-based gene therapy, CAR T-cell therapy involves altering the genetic makeup of T cells, equipping them with the ability to target specific cancer antigens.
This innovative treatment has demonstrated remarkable efficacy, particularly in cases where conventional therapies have proven ineffective. Its ability to reprogram the immune system to target and destroy cancer cells marks a significant advancement in cancer treatment strategies.
Classification:
CAR T cell therapy is classified as follows:
- Structure-based classification:
- First-generation CAR T-cells: These CAR T-cells typically consist of an antigen-binding domain (single-chain variable fragment, scFv) linked to a T-cell activation domain, such as the CD3ζ chain. They lack additional co-stimulatory domains.
- Second-generation CAR T-cells: These CAR T-cells include an additional co-stimulatory domain, such as CD28 or 4-1BB (CD137), along with the CD3ζ chain. The presence of co-stimulatory domains enhances T-cell activation and persistence.
- Third-generation CAR T-cells: These CAR T-cells incorporate two co-stimulatory domains along with the CD3ζ chain, aiming to further enhance T-cell function and anti-tumor activity.
Antigen-based classification: It includes
- CD19-targeted CAR T-cells: CD19 is a common target for CAR T-cell therapy and is used in the treatment of B-cell malignancies such as acute lymphoblastic leukemia (ALL) and certain types of lymphoma.
- Other antigen-targeted CAR T-cells: CAR T-cells can be engineered to target a variety of antigens expressed on cancer cells, including but not limited to BCMA (B-cell maturation antigen), CD22, CD30, and EGFRvIII.
- T-cell harvesting: T cells are removed from the patient's blood by processing.
- Genetic alteration: T cells are designed in the laboratory to express CAR proteins targeting cancer cells.
- Expansion: Modified T cells are expanded to therapeutic levels.
- Infusion: Patient receives an intravenous infusion of CAR T cells.
- Monitoring: Intensive monitoring, often in the hospital, for side effects and reactions.
- Cytokine Release Syndrome (CRS)
- Neurotoxicity
- Infections
- Low blood counts
- Relapse or non-response
Would you like some help? We are available.
Get Help
Prince Court Medical Centre
Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.
BLK-Max Super Speciality Hospital
Delhi, India
BLK-Max Super Speciality Hospital, located in New Delhi, is the leading best-in-class healthcare institution in India, providing tertiary and quaternary care. 650 + beds including 162 critical care beds, 22 OTs with 1,500+ clinical professionals allied to health are at the hospital's disposal. JCI, NABH, and NABL accredited. The hospitals are a leader in transplants, cancer care, and robotic surgery education and implementation. Established in1959 by Dr. B.L. Kapur, the hospital combines state-of-the-art technology with patient-centric values including compassion, efficiency, and consistency.
Kings College Hospital Dubai
Dubai, United Arab Emirates
Types of CAR-T in Kings College Hospital Dubai and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (AED) |
|---|---|---|
| CAR-T | 134535 - 444996 | 500036 - 1640705 |
- Address: King's College Hospital London, Dubai, East Exit - Al Marabea' Street - Dubai - United Arab Emirates
- Facilities related to Kings College Hospital Dubai: Choice of Meals, Interpreter, SIM, TV inside room, Accommodation
Artemis Health Institute
Gurgaon, India
Artemis Hospital, established in 2007 in Gurgaon, India, is a 750+ bed, state-of-the-art multi-speciality hospital and the first in Gurgaon accredited by JCI and NABH. A flagship of the Apollo Tyres Group, it offers advanced care across cardiology, oncology, orthopaedics, neurology, and transplant medicine, supported by modern infrastructure and 60+ world-class operating theatres. Its Centres of Excellence span critical areas like heart, cancer, neurosciences, orthopaedics, and women & child care. Guided by values of Service, Compassion, and Integrity, Artemis combines innovation, technology, and affordability, making it a trusted international healthcare destination for comprehensive and compassionate patient care.
Sunway Medical Centre
Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.
Bangpakok 9 International Hospital
Bangkok, Thailand
Types of CAR-T in Bangpakok 9 International Hospital and its associated cost
| Treatment Option | Approximate Cost Range (USD) | Approximate Cost Range (THB) |
|---|---|---|
| CAR-T | 165679 - 512937 | 6049864 - 18091595 |
- Address: Bangpakok 9 International Hospital, International Hospital, Rama II Road, Bang Mot, Chom Thong, Bangkok, Thailand
- Facilities related to Bangpakok 9 International Hospital: Choice of Meals, Interpreter, SIM, TV inside room, Accommodation
Medipol Bahçelievler Hospital
Istanbul, Turkey
Medipol Bahcelievler Hospital is a medical institution providing a full range of medical and individualized approaches to its patients. Medipol has the ambition to bring high quality and maximum security to people in need by employing state-of-the-art technologies in medicine. They ensure that the health of the patients is improved by fashioning unique physician specialty treatment programs.
Medipol Bahcelievler Hospital provides an exceptional position in the healthcare industry with a policy of clear communication, professionalism, and reliability to patient expectations. Medipol Bahçelievler Hospital is situated in the European Side of Istanbul, dedicated to 24-hour health care for you and your loved ones, equipped with a fully functional operation theatre and ICUs with state-of-the-art equipment, laboratory, emergency, and advanced treatment rooms
Medanta - The Medicity
Gurgaon, India
Medanta – The Medicity, Gurugram, founded by renowned cardiac surgeon Dr. Naresh Trehan, is a leading multi-super speciality hospital offering advanced yet affordable healthcare. Spread across a 43-acre campus, it houses 1,391 beds, 270 ICU beds, 40 operation theatres, and 900+ doctors across 30+ specialities. Accredited by JCI, NABH, and NABL, Medanta is designed per American Institute of Architects’ healthcare guidelines. Recognised as the Best Private Hospital in India (2020–2025) and among the World’s Top 250 Hospitals (Newsweek 2024), it excels in Cardiac Care, Cancer, Neurosciences, Gastro, Orthopaedics, and Renal Care, ensuring world-class, collaborative, and compassionate treatment.
ParkCity Medical Centre
Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.
Subang Jaya Medical Centre
Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Need Some Advice From Our Experts?
Request a Call Back Now!
Our team of healthcare experts would be happy to assist you
+99Process Involved for CAR-T
- Preoperative Stage: An assessment of the patient's medical history, including testing to determine eligibility for CAR-T therapy and identify the target antigen on cancer cells.
- Treatment Plan Discussion: An oncologist discusses the procedure of CAR-T therapy, including potential dangers, advantages, and side effects.
- Therapeutic Stage: T-cells are extracted from the patient, modified in the lab to express a chimeric antigen receptor (CAR), and reintroduced into the patient to target and destroy cancer cells.
- Postoperative Phase: Closely monitor for side effects. Follow-ups are scheduled regularly to check the response and treat any complications.
- Cancer patients, especially those suffering from blood cancers like leukemia, lymphoma, and multiple myeloma.
- Patients who have not responded to previous therapies, such as chemotherapy or radiation.
- Patients in good overall health with a functioning immune system.
- Individuals who have specific genetic markers that qualify them for CAR-T treatment.
- Targeted Action: CAR-T treatment specifically targets cancer cells, increasing efficacy while minimising damage to healthy cells.
- Potential for Remission: Can result in long-term remission, even in people with difficult-to-treat cancer.
- Minimally Invasive: The treatment consists mainly of an outpatient procedure for T-cell collection, with the therapy provided via infusion.
- Fill out the inquiry form: Fill out the form to provide us with the relevant information about your condition.
- Consult with Our Healthcare Expert: One of our qualified specialists will contact you for a consultation.
- Receive a Detailed Treatment Plan: After examining your situation, we will provide you with a detailed treatment plan that includes expert views and cost breakdowns for various choices.
- Choose your preferred option: Choose the treatment option that suits you the best.
